NASDAQ:KURA

Kura Oncology Stock Predictions

Healthcare > Biotechnology

Buy KURA

*Your capital is at risk

$8.66

-0.315 (-3.51%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

KURA Prediction Chart

KURA Predictions History

Latest community submissions for KURA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Sep 15, 2017	$12.56 -3.01%	$12.95	X	97.00%	0
JS Pro	Sep 14, 2017	$11.45 -13.58%	$13.25	X	86.40%	0
JS Pro	Apr 19, 2016	$3.31 +0.30%	$3.30	X	99.70%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KURA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT KURA ONCOLOGY

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by